pharmaphorum

JUNE 23, 2022

Systemic administration of gene-editing drugs would avoid that process with an “off-the-shelf” option for a one-shot, potentially curative treatment for diseases associated with genetic mutations. billion agreement that started in 2020.

Gene Editing 97

Gene Editing In-Vivo Gene Sequencing Gene 97

pharmaphorum

AUGUST 10, 2021

million for the one-shot therapy, which was approved in 2019 but faced a delayed launch because of manufacturing problems. At the time, the biotech said it would also reduce staff and restructure its European business in order to focus on “priority” markets. bluebird had set an initial price of $1.8

Gene Therapy 135

Gene Therapy Gene Marketing Genetic Disease 135

pharmaphorum

OCTOBER 12, 2022

The neoantigens are selected based on gene sequencing of either a tumour biopsy or a blood sample, with an individual vaccine tailored to the patient manufactured and administered in a matter of weeks.

Vaccination 105

Vaccination Vaccine Gene Sequencing RNA 105

Roots Analysis

FEBRUARY 21, 2022

Since the introduction of a gene sequencing method by Frederick Sanger in 1977, the field of genomic data collection and analysis has evolved significantly. Advancement in DNA sequencing technologies have resulted in noteworthy developments in various healthcare-related research fields, such as diagnostics and personalized medicine.

Marketing 52

Marketing Gene Sequencing DNA Genome 52

Roots Analysis

FEBRUARY 23, 2022

For more details on this emerging domain, check out the following report : Next Generation Sequencing (NGS) Library Preparation Kits. Our Social Media Platform. Web: [link]. LinkedIn: [link]. Twitter: [link].

Genetics 52

Genetics DNA RNA Reagent 52

Pharmaceutical Technology

MAY 26, 2023

Tripling its production capacity, Touchlight can now manufacture 8kg plasmid DNA, a key component for mRNA gene therapies and vaccines. As per the company, dbDNA is suitable for rapid, scalable manufacture of GMP DNA and can incorporate gene sequences of sizes ranging from 500bp to 20kb, which are typically unstable as pDNA.

DNA 130

DNA Manufacturing Gene Gene Therapy 130

pharmaphorum

FEBRUARY 19, 2021

The injectable single-dose Ebola vaccine is manufactured by MSD, known as Merck & Co in the US and Canada. Since 2020 there has been a 50% increase in sequences produced in African countries. On 15 February, the WHO gave emergency use listing to Oxford/AstraZeneca’s COVID-19 vaccine. Novavax has also signed a deal to provide 1.1

Vaccination 64

Vaccination Vaccine Gene Sequencing Manufacturing 64